Molecular design and delivery of extracellular and membrane protein degradation chimeras
Advanced Drug Delivery Reviews · 2026-12 · 239 · 115959
DOI: 10.1016/j.addr.2026.115959 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-12. Verfasst von Shutong Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Biology & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 20120…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Drug Design, Membrane Proteins. Die Arbeit nennt 208 Literaturangaben. Gefördert von: Chinese Academy of Sciences, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Extracellular and membrane-associated proteins constitute a substantial therapeutic target space that remains largely inaccessible to intracellular degradation strategies based on the ubiquitin-proteasome system. Membrane and extracellular targeted protein degradation (meTPD) addresses this limitation by coupling target recognition to degradation-competent uptake and intracellular sorting rather than relying on a single receptor or platform. In this Review, we organize meTPD strategies according to their trafficking and degradation routes, including lysosome-targeting receptor-dependent systems, transmembrane E3 ligase recruitment, receptor-independent internalization, lysosomal-sorting sequences and autophagy-mediated clearance. We then examine how ligand affinity and epitope accessibility, ternary-complex geometry, linker architecture, covalency, valency, receptor recycling and degrader reuse collectively determine productive degradation. Particular attention is given to spatial selectivity across tissues, cell populations and subcellular organelles, as well as to artificial intelligence-assisted design, stimuli-responsive activation and delivery systems that regulate the exposure and trafficking of meTPDs. Finally, we discuss emerging clinical evidence, convergence with antibody-drug conjugate-derived modalities, the hook effect and plausible resistance mechanisms. By integrating molecular design, receptor biology, intracellular trafficking, delivery and pharmacodynamic considerations, this review provides a framework for selecting disease-matched degradation routes and advancing meTPDs from platform-specific demonstrations towards predictable therapeutic modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Biology & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, C…
- State Key Laboratory of Chemical Biology & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Chemistry and Molecular Engineering, East China No…
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China.
- School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK. Electronic address: zheying.zhu@nottingham.ac.uk.
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China. Electronic address: zaxu@ecnu.chem.edu.cn.
Förderung
- Chinese Academy of Sciences
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
- State Key Laboratory of Medicinal Chemical Biology
Zitieren
APA
Lin, S., Zhou, H., Qiu, J., Dang, Y., Kou, L., Zhu, Z., Xu, Z., Lai, Y., & Yu, H. (2026). Molecular design and delivery of extracellular and membrane protein degradation chimeras. Advanced Drug Delivery Reviews, 239, 115959. https://doi.org/10.1016/j.addr.2026.115959
Vancouver
Lin S, Zhou H, Qiu J, Dang Y, Kou L, Zhu Z, et al. Molecular design and delivery of extracellular and membrane protein degradation chimeras. Advanced Drug Delivery Reviews. 2026;239:115959. doi:10.1016/j.addr.2026.115959
BibTeX
@article{Lin2026,
author = {Lin, Shutong and Zhou, Huiling and Qiu, Jiayan and Dang, Yijing and Kou, Longfa and Zhu, Zheying and Xu, Zhiai and Lai, Yi and Yu, Haijun},
title = {Molecular design and delivery of extracellular and membrane protein degradation chimeras},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {239},
pages = {115959},
doi = {10.1016/j.addr.2026.115959}
}
EUVIMED